<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Edinburgh Research Explorer</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Aggressive</forename><surname>Epidermotropic</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Cutaneous</forename><forename type="middle">Cd8+</forename><surname>Lymphoma</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Department of Pathology</orgName>
								<address>
									<settlement>Clermont-Ferrand</settlement>
								</address>
							</affiliation>
							<affiliation key="aff20">
								<orgName type="department">Department of Pathology</orgName>
								<address>
									<settlement>Clermont-Ferrand</settlement>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><roleName>Dr</roleName><forename type="first">Alistair</forename><surname>Robson</surname></persName>
							<email>alistair.robson@kcl.ac.uk</email>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution">St John&apos;s Institute of Dermatology</orgName>
								<address>
									<settlement>London</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Dept. of Dermatology</orgName>
								<orgName type="department" key="dep2">Dept. of Pathology Universite</orgName>
								<orgName type="department" key="dep3">Dept. of Dermatology</orgName>
								<orgName type="institution">Charité-University Medicine</orgName>
								<address>
									<settlement>Berlin, Paris</settlement>
									<region>3), (4</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="institution">Venereology University of Zurich</orgName>
								<address>
									<settlement>Lille</settlement>
									<region>(5) CHRU</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department">Department of Dermatology Medical</orgName>
								<orgName type="institution">University of Graz</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department">Dept. of Dermatology</orgName>
								<orgName type="institution">University of L&apos;Aquila</orgName>
								<address>
									<settlement>Rome</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">Dept. of Dermatology Gent</orgName>
								<orgName type="department" key="dep2">Dept. of Pathology Western General Hospital</orgName>
								<address>
									<settlement>Edinburgh</settlement>
									<region>(12</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="department" key="dep1">Dept. of Dermatology</orgName>
								<orgName type="department" key="dep2">Dept. of Pathology</orgName>
								<orgName type="institution" key="instit1">University of Vienna</orgName>
								<orgName type="institution" key="instit2">VU University Medical Center Amsterdam</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff8">
								<orgName type="institution" key="instit1">) Hospital Universitario</orgName>
								<orgName type="institution" key="instit2">Universidad Complutense</orgName>
								<address>
									<settlement>Madrid</settlement>
									<region>(15</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff9">
								<orgName type="department">Dept. of Pathology of Dijon&apos;s University Hospital</orgName>
								<address>
									<settlement>Dijon</settlement>
									<region>(16</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff10">
								<orgName type="department">Division of Dermatology</orgName>
								<orgName type="institution">University of Florence Medical School</orgName>
								<address>
									<settlement>Florence</settlement>
									<region>(17</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<orgName type="department" key="dep1">Division of Pathological Anatomy</orgName>
								<orgName type="department" key="dep2">Department of Pathology Henri-Mondor hospital</orgName>
								<orgName type="institution">University of Florence</orgName>
								<address>
									<settlement>Florence</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff12">
								<orgName type="department">Dept. of Dermatology</orgName>
								<orgName type="institution" key="instit1">University Paris-Val-de-Marne</orgName>
								<orgName type="institution" key="instit2">Leiden University</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff13">
								<orgName type="department">Dept. of Dermatology</orgName>
								<address>
									<region>Milan</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff14">
								<orgName type="department">Dept. Dermatopathology 2 nd Floor</orgName>
								<orgName type="institution">South Wing St. John&apos;s Institute of Dermatology St Thomas&apos; Hospital</orgName>
								<address>
									<addrLine>Block C, Westminster Bridge Road</addrLine>
									<postCode>SE1 7EH</postCode>
									<settlement>London</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff15">
								<orgName type="institution">St John&apos;s Institute of Dermatology</orgName>
								<address>
									<settlement>London</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff16">
								<orgName type="department" key="dep1">Dept. of Dermatology</orgName>
								<orgName type="department" key="dep2">Dept. of Pathology Universite</orgName>
								<orgName type="department" key="dep3">Dept. of Dermatology &amp; Venereology</orgName>
								<orgName type="institution">Charité-University Medicine</orgName>
								<address>
									<settlement>Berlin, Paris</settlement>
									<region>3), (4</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff17">
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Lille</settlement>
									<region>(5) CHRU</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff18">
								<orgName type="department">Department of Dermatology Medical</orgName>
								<orgName type="institution">University of Graz</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff19">
								<orgName type="department">Dept. of Dermatology</orgName>
								<orgName type="institution">University of L&apos;Aquila</orgName>
								<address>
									<settlement>Rome</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff21">
								<orgName type="department" key="dep1">Dept. of Dermatology Gent</orgName>
								<orgName type="department" key="dep2">Dept. of Pathology Western General Hospital</orgName>
								<address>
									<settlement>Edinburgh</settlement>
									<region>(12</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff22">
								<orgName type="department" key="dep1">Dept. of Dermatology</orgName>
								<orgName type="department" key="dep2">Dept. of Pathology</orgName>
								<orgName type="institution" key="instit1">University of Vienna</orgName>
								<orgName type="institution" key="instit2">VU University Medical Center Amsterdam</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff23">
								<orgName type="institution" key="instit1">) Hospital Universitario</orgName>
								<orgName type="institution" key="instit2">Universidad Complutense</orgName>
								<address>
									<settlement>Madrid</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff24">
								<orgName type="institution">) Dept. of Pathology of Dijon&apos;s University Hospital</orgName>
								<address>
									<settlement>Dijon</settlement>
									<region>(16</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff25">
								<orgName type="department">Division of Dermatology</orgName>
								<orgName type="institution">University of Florence Medical School</orgName>
								<address>
									<settlement>Florence</settlement>
									<region>(17</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff26">
								<orgName type="department">Division of Pathological Anatomy</orgName>
								<orgName type="institution">University of Florence</orgName>
								<address>
									<settlement>Florence</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff27">
								<orgName type="department">Department of Pathology Henri-Mondor hospital</orgName>
								<orgName type="institution">University Paris-Val-de-Marne</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff28">
								<orgName type="institution">) Dept. of Dermatology Leiden University</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff29">
								<orgName type="department">Dept. of Dermatology</orgName>
								<address>
									<region>Milan</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Edinburgh Research Explorer</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">5F1AA719C115673FE345657F003EFEDE</idno>
					<idno type="DOI">10.1111/his.12371</idno>
					<note type="submission">Link to publication record in Edinburgh Research Explorer This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process which may lead to differences between this version and the Version of Record. Please cite this article as an &apos;Accepted Article&apos;, doi: 10.1111/his.12371 Accepted Article This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process which may lead to differences between this version and the Version of Record. Please cite this article as an &apos;Accepted Article&apos;, Received Date : 21-Aug-2013 Revised Date : 06-Nov-2013 Accepted Date : 12-Jan-2014 Article type : Original Article</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:31+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Peer reviewed version lymphoma</term>
					<term>CD8 antigen</term>
					<term>mycosis fungoides</term>
					<term>diagnosis</term>
					<term>prognosis</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Aggressive epidermotropic cutaneous CD8+ lymphoma is currently afforded provisional status in the WHO classification of lymphomas.</s><s>An EORTC Workshop was convened to describe in detail the features of this putative neoplasm and evaluate its nosological status with respect to other cutaneous CD8+ lymphomas.</s></p><p><s>Methods &amp; Results: Sixty-one CD8+ cases were analysed at the workshop; clinical details, often with photographs, histological sections, immunohistochemical results, treatment and patient outcome were discussed &amp; recorded.</s><s>Eighteen cases had distinct features and conformed to the diagnosis of aggressive epidermotropic cutaneous CD8+ lymphoma.</s><s>The patients typically present with widespread plaques and tumours, often ulcerated and haemorrhagic, and have striking pagetoid epidermotropism histologically.</s><s>A CD8+ CD45RA+ CD45RO-CD2-CD5-CD56-phenotype, with 1 or more cytotoxic markers was found in 7/18 with a very similar phenotype in the remainder..</s><s>The tumours seldom involve lymph nodes but mucosae and central nervous system involvement are not uncommon.</s><s>The prognosis is poor, with a median survival of 12 months.</s><s>Examples of CD8+ mycosis fungoides, lymphomatoid papulosis and Woringer-Kolopp presented the typical features well documented in the CD4+ forms of those diseases.</s></p><p><s>Conclusions: Aggressive Epidermotropic Cutaneous CD8+ Lymphoma is a distinct lymphoma that warrants inclusion as a distinct entity in future revisions of lymphoma classifications.</s></p><p><s>Aggressive Epidermotropic Cutaneous CD8+ Lymphoma: A cutaneous lymphoma with distinct clinical and pathological features.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>There has been consensus in the classification of cutaneous lymphoma culminating in the publication of the WHO lymphoma classification with its distinct section of cutaneous lymphomas¹.</s><s>This document acknowledges the completely different clinical behaviour and prognosis of many primary cutaneous lymphomas when compared to their counterparts arising at other sites.</s></p><p><s>While there remains little controversy with respect to mycosis fungoides, Sezary syndrome and primary cutaneous CD30+ lymphoproliferations, the remaining group of diseases, constituting &lt; 10% of cutaneous lymphomas, are more problematic.</s><s>In particular, a provisional category has been retained for two putative entities, viz.</s><s>Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma &amp; primary cutaneous aggressive CD8+ T-cell lymphoma.</s><s>Although there is presumptive evidence to support the inclusion of these as bona fide categories, it has been concluded that more data are required before granting each unequivocal status as a clinico-pathological entity distinct from other forms of cutaneous lymphoma.</s><s>A meeting of the EORTC was convened in London, in which cases of primary cutaneous CD8+ lymphoma were assembled from many centres across Europe, discussed and, more specifically, the potential status of primary cutaneous aggressive CD8+ T-cell</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s><s>lymphoma as a disease entity considered.</s><s>The findings of the conference indicate this lymphoma has distinct clinical, pathological and immunophenotypic features thus supporting the inclusion of this lymphoma as a separate category in future revisions of the consensus classification.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Material and Methods Cases</head><p><s>A total of 71 examples of CD8+ lymphoma were submitted for inclusion in the study by the members of the EORTC Cutaneous Lymphoma Task Force.</s><s>The following data were recorded: sex, age at diagnosis, site of manifestation, clinical presentation, involvement of other organs, therapy, length of follow-up and outcome.</s><s>Juvenile CD8+ hypopigmented mycosis fungoides has been the subject of several publications, is widely acknowledged as a particular variant of T-cell lymphoma, and no cases were submitted for consideration.</s><s>Furthermore, subcutaneous T-cell lymphoma was actively excluded as this disease formed the basis of a separate workshop.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Pathology Studies</head><p><s>All biopsy specimens were routinely processed and embedded in paraffin.</s><s>According to available material, 5μm tissue sections were cut and stained with haematoxylin and eosin, and by immunohistochemistry for the antibodies listed in Table <ref type="table" target="#tab_1">1</ref>.</s><s>Expression by &gt;75% of cells was defined as positive, &lt;10% negative, 10-75% +/-.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 1. Antibodies used for immunophenotyping.</head><p><s>The cases were reviewed and classified by attending pathologists and dermatologists in discussion in a lecture theatre and around a multiheaded microscope.</s><s>A consensus was defined as no individual author dissented.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analysis</head><p><s>Survival time was calculated from the date of histologically confirmed diagnosis until the lymphoma-related death or latest known follow-up using SAS 9.2 statistical package.</s><s>The cut-off level for statistical significance was set at 0.05 in all analyses.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Definition of Groups</head><p><s>Based on the collected clinical, histological and immunohistochemical data three principal groups were defined.</s><s>The majority of cases (34) could be classified as CD8+ mycosis fungoides; there were 6 cases of CD8+ lymphomatoid papulosis, 1 of CD8+ lymphomatoid papulosis -cutaneous anaplastic large cell lymphoma overlap and 2 cases of pagetoid reticulosis.</s><s>Eighteen cases were distinct from these groups and matched the previous descriptions of primary cutaneous aggressive CD8+ T-cell lymphoma.</s><s>Ten cases were rejected from the study.</s><s>These were as follows: three cases were either deemed unclassifiable (primary cutaneous T-cell lymphoma NOS according to the EORTC -WHO consensus classification, e.g. an unusual double CD4+ /CD8+ lymphoma arising in an HIV+ patient) or formed isolated sundry albeit well-recognised diseases -HTLV-1+ CD8+ lymphoma and CD8+ ATLL.</s><s>Seven further cases had insufficient details supplied for inclusion; all these were rejected &amp; took no further part in the study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mycosis fungoides (MF) with CD8 phenotype</head><p><s>This group constituted the majority of submitted cases, 20 males and 14 females with a mean age of 49.6 years (males 53, females 46.3 years) (Table <ref type="table" target="#tab_0">2</ref>).</s><s>A crucial feature of this group was the clinical presentation of patches and plaques typical of classical mycosis fungoides (Figs <ref type="figure" target="#fig_0">1a-c &amp; 1d</ref>).</s><s>The distribution of disease did not differ from classical CD4+ MF.</s><s>The cases presented the histomorphology usually associated with, and welldocumented in, classical MF.</s><s>Thus, epidermotropism, tagging along the basal epidermal layer (Fig. <ref type="figure">1e</ref>), Pautrier microabscesses, variable dermal infiltrate of pleomorphic cells having cerebriform nuclear contours were each seen to varying degrees in this group.</s><s>The dermal infiltrate varied in accord with patch, plaque or tumour stage of disease.</s><s>No features appeared to distinguish the group from commonplace CD4+ MF.</s><s>By definition a majority of tumour cells expressed CD8 (Fig <ref type="figure">1f</ref>); all failed to react with the CD4 antibody.</s><s>The majority of cases labelled with one or both of granzyme B and TIA-1.</s><s>A single case expressed CD56.</s><s>In 23 cases of CD8+ MF so tested 18 were CD45RO+.</s><s>Of 15 tested all expressed CD2, whilst of 16 tested 11 labelled with CD5.</s><s>Ki-67 was assessed in 19 and revealed a low proliferative fraction (10-&lt;50%) in all.</s></p><p><s>Similarly, following a variety of accepted treatment regimens commonly used in mycosis fungoides survival time mirrored the more common CD4 form of the disease (Fig. <ref type="figure" target="#fig_1">1g</ref>); all but two patients are still alive, having received a variety of standard therapies after a median of 47 months.</s><s>Treatments included; PUVA, UVB, topical steroids, nitrogen mustard, radiotherapy, methotrexate, miltefosine, cyclophosphamide, gemcitabine, alpha-interferon, bexarotene, TSEB &amp; CHOP.</s><s>These 6 patients presented with groups of ulcerating papules and nodules, which characteristically waxed and waned, in the typical manner of LyP (Table <ref type="table" target="#tab_0">2</ref>).</s><s>In two cases the lesions had a haemorrhagic appearance, but otherwise did not differ appreciably from classical LyP.</s><s>All patients followed a benign clinical course, having been treated with standard therapeutic regimens, which included simple follow up, PUVA &amp; methotrexate.</s></p><p><s>Histologically, a wedge-shaped infiltrate with a mixed population of cells, including large atypical mononuclear CD30+ cells, was seen in 4 cases, with a further case having sheets of anaplastic cells typifying type C. In a single case the infiltrate comprised smaller CD30-cells akin to those seen in MF, typical of LyP type B. One additional case was</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s><s>classified as LyP/ALCL overlap, and presented as a solitary nodule, which regressed.</s><s>Histologically there was a dense population of CD30+ CD8+ T-cells with relatively few admixed inflammatory cells.</s><s>The patient remains well.</s><s>None of the cases conformed to the recently described lymphomatoid papulosis type D, in which the CD8+ lesional cells infiltrate the epidermis with a pagetoid reticulosis pattern.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Solitary pagetoid reticulosis (Woringer-Kolopp)</head><p><s>Two patients presented with solitary hyperkeratotic erythematous patches characteristic of the solitary form of pagetoid reticulosis, a recognised variant of MF.</s><s>Histologically, there was marked pagetoid epidermotropism of medium-sized atypical mononuclear T-cells.</s><s>Neither patient has progressive disease, with each responding to local directed therapy, UVB and steroids (Table <ref type="table" target="#tab_0">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma</head><p><s>In 18 cases there was consensus that the lymphoma differed substantially from cases included in the previous groups.</s><s>The clinical details of this group of patients are summarised in Table <ref type="table">3a</ref>.</s><s>These patients were mainly adult with 11 males &amp; 7 females, and a mean age of 54.5 years (males 51.6, females 59.4; range 27-87).</s><s>The clinical presentation not only differed from usual MF, lacking the patches and plaques that define that disease, but displayed lesions that had many similar features.</s><s>Lesions were located in multiple sites including the trunk, arms and legs, and face.</s><s>Mucosal (oral) disease was noted at presentation in 2 cases.</s><s>Ulcerated crusted and nodular lesions were most common, often with haemorrhagic foci.</s><s>Infiltrated plaques or tumours manifest early in the disease (Figs.</s><s>2a-g); Clinical follicular involvement was not a feature commented upon in any case.</s><s>In two patients a limited number of tumours, particularly on the face, led to the patient presenting (Fig. <ref type="figure">2h</ref>).</s><s>No patient gave a long history of scaly patches or poikiloderma to suggest an evolution from a more indolent prodromal period.</s><s>One patient had a history of rheumatic fever and a clinical diagnosis of vasculitis was initially made.</s><s>Staging procedures, in 17 patients, including chest X-rays, abdominal, chest and total body CT scans, revealed enlarged lymph nodes in only one instance at presentation, found to be reactive on biopsy, confirming the lesions to be primary cutaneous.</s><s>Bone marrow investigations in all patients failed to reveal involvement by disease.</s><s>In 13 cases the patients rapidly succumbed to the disease, with a median survival of 12 months.</s><s>A variety of therapies had been used in these patients; 13 patients underwent chemotherapy or immunotherapy, with or without radiotherapy or PUVA.</s><s>While a few patients enjoyed a partial response, only 1 had a complete response recorded, who then subsequently relapsed and died.</s><s>Two patients underwent autopsy examinations: in one, no evidence of visceral disease was found; the other had widespread involvement of liver, lungs, spleen, heart and mediastina lymph nodes.</s><s>HIV status was negative in the 10 patients investigated; HTLV-1 status was assessed in 4 and was negative.</s><s>Survival differed significantly from the MF group, with a median survival of 12 months (p &lt; 0.002) (Fig <ref type="figure" target="#fig_1">1g</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 3a Primary Cutaneous Aggressive Epidermotropic CD8+ Lymphoma</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figs. 2a-g. Presentations of aggressive epidermotropic CD8+ lymphoma included widespread ulcerated plaques and tumours, a) often haemorrhagic; b) haemorrhagic plaques on the chest and trunk &amp; limbs of these patients: c) ulcerated tumours &amp; plaques (same patient as "a": d) deeply ulcerated tumour: e) Disseminated ulcerated</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s><s>haemorrhagic plaques.</s><s>This patient had no visceral disease at autopsy; f) haemorrhagic necrotic plaques: g) Ulcerated tumours on the head and trunk.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Fig. 2h. Aggressive epidermotropic CD8+ lymphoma; a solitary periorbital mass, clinically mimicking extranodal NK/T-cell lymphoma and blastic plasmacytoid dendritic cell neoplasm.</head><p><s>Biopsies had been taken from a variety of clinical lesions, and this was reflected in the histology.</s><s>Thus, ulceration was common, being observed in 14 patients.</s><s>Erythematous hyperkeratotic plaques typically revealed hyperkeratosis and/or acanthosis, and striking epidermotropism.</s><s>The epidermotropism was a conspicuous observation in 15 cases, conforming to a pagetoid reticulosis pattern i.e. single atypical cells liberally replacing the epidermis albeit most concentrated in the lower portion (Fig <ref type="figure">3a-d</ref>).</s><s>Pautrier microabscesses were conspicuously lacking despite the number of malignant cells, only being noted in two cases, and then a minority feature; similarly, lining of atypical cells along the epidermal basal layer -"tagging" -was never an observation; the epidermis was simply liberally peppered by individual atypical cells akin to that seen in solitary and diffuse forms of pagetoid reticulosis.</s><s>Folliculotropism was noted in 8 cases of 11 in which follicles were well seen (Figs.</s><s>4a &amp;b), with a similar pattern of single cell infiltration, albeit often florid, but mucinous degeneration of follicles was absent, and follicular disease was in all cases overshadowed by the interstitial and epidermal infiltrate; malignant cells permeated between eccrine glands in 5 cases of 8 in which these were clearly visualised but syringotropism proper was not convincing, present focally in a single case (Figs.</s><s>5a &amp;b).</s><s>A diffuse and dense dermal population of pleomorphic cells was found in biopsies of the clinical tumours.</s><s>Angiocentricity was a common finding (Figs.</s><s><ref type="figure">6a-d</ref>), observed in 11 biopsies, sometimes accompanied by angiodestruction.</s><s>Ischaemic necrosis within the dermis was pronounced in 2 cases and ischaemic necrosis of the epidermis in 5.</s><s>The dermal infiltrate consisted of medium-sized but quite monotonous atypical cells in the vast majority of cases.</s><s>The majority of cells in most cases had enlarged hyperchromatic rounded nuclei frequently with a coarse chromatin pattern (Fig. <ref type="figure" target="#fig_3">7</ref>).</s><s>The cerebriform nuclear contour, the hallmark of MF, was not present in the majority of cells in any case, although perinuclear halos were often seen.</s><s>Nodular collections of large highly pleomorphic/anaplastic cells that characterise "high grade" transformation in MF were not seen in any case.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figs. 3a-d. A pagetoid reticulosis pattern of epidermotropsim was characteristic of aggressive epidermotropic CD8+ lymphoma, without</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s></p><p><s>A variable interstitial component, and occasional subcutaneous extension, without adipocyte rimming, were other unremarkable sundry observations.</s><s>The results of immunophenotyping these cases are presented in Table <ref type="table" target="#tab_3">3b</ref>.</s><s>Several characteristic traits emerged within this group.</s><s>Most <ref type="bibr" target="#b13">(14)</ref> cases lacked CD2 and/or CD5, and expressed CD45RA (14 cases, Figs.</s><s><ref type="figure">8a-d</ref>).</s><s>Conversely, only 3 of 17 presented a population of cells that labelled with antibody to CD45RO, and in these few cells were positive.</s><s>Of 10 cases investigated for Beta-F1 expression, 8 were positive in the tumour cells.</s><s>A high proliferative fraction with Ki-67 was found in all but 2 cases investigated.</s><s>The neoplastic cells in each case expressed one or both of TIA-1 or granzyme B; none expressed CD30 or CD56.</s><s>All tumours were negative with in-situ hybridisation for EBER.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 3b Immunophenotype of Primary Cutaneous Aggressive</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion.</head><p><s>The literature reports of "CD8+ lymphomas" suggest a markedly variable patient outcome.</s><s>Agnarsson et al divided CD8+ lymphomas into progressive and indolent groups.</s><s>The former presented with infiltrated plaques and nodules, the latter had chronic patches typical of mycosis fungoides <ref type="bibr" target="#b1">(2)</ref>.</s><s>Other authors emphasise, either the aggressive nature of CD8+ lymphoma <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b3">4)</ref>, a benign clinical course and/or that CD8 expression by neoplastic cells cannot be assumed to impart a poor prognosis <ref type="bibr" target="#b4">(5,</ref><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b48">49,</ref><ref type="bibr" target="#b60">61)</ref>.</s><s>Hagiwara et al studied a series of CD8+ epidermotropic lymphomas and found spontaneous regression in 80% with only 1 fatality of 5 patients <ref type="bibr" target="#b7">(8)</ref>.</s><s>However, little clinical description was provided, and the possibility of lymphomatoid papulosis types D &amp; E (31; see below) not considered.</s></p><p><s>Recent classifications of primary cutaneous lymphomas have emphasised the collective importance of clinical, pathological and immunophenotypic parameters in delineating disease entities.</s><s>Mycosis fungoides, lymphomatoid papulosis and CD30 lymphoproliferation, the most common T-cell lymphoid neoplasms, have well-established clinical features and pathological morphologies.</s><s>There remain a group of rarer malignancies in which a paucity of data has undermined attempts to definitively assess nosological status and clinicopathological details.</s><s>In 1999, Berti et al reported a series of 17 patients with cytotoxic lymphoproliferative disorders, variably characterised as lymphomatoid papulosis, anaplastic large cell lymphoma, mycosis fungoides and cases of a hitherto unreported aggressive epidermotropic form of CD8+ disease <ref type="bibr" target="#b8">(9)</ref>.</s><s>These latter cases differed from the more common mycosis fungoides clinically and histopathologically.</s><s>Since then there have been a number of isolated reports that attest to this distinctive entity <ref type="bibr" target="#b9">(10,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b49">50)</ref>. It is accepted that MF, LyP and anaplastic large cell lymphoma may, exceptionally, display a cytotoxic phenotype.</s><s>In such cases successful diagnosis rests on careful clinical and histological appraisal; thus, these diseases present the "usual" clinical and histological features of these disorders and simply differ in the cytotoxic phenotype of the neoplastic cells.</s><s>Nevertheless, formal evaluation of these variants and comparisons with the provisionally accepted aggressive epidermotropic cytotoxic lymphoma of Berti has been wanting.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s></p><p><s>In this paper, the clinical, histological and immunphenotypic characteristics of forms of CD8+ cutaneous lymphoproliferative disease have been collected and analysed.</s><s>These proliferations encompass mycosis fungoides, lymphomatoid papulosis, anaplastic large cell lymphoma, Woringer-Kolopp and the provisional entity aggressive epidermotropic cytotoxic lymphoma.</s></p><p><s>Of the cases submitted, 34 had the classic clinical phenotype of mycosis fungoides (MF).</s><s>Thus, nothing in the presentation and clinical appraisal distinguished these patients from commonplace CD4 disease.</s><s>Indeed, the first and only unusual characteristic was the finding of a CD8 immunophenotype on biopsy material.</s><s>The other immunocytochemical findings were largely unextraordinary; a single case was CD56+, and the observation of T-cell antigen loss, when observed, did not conform to a particular pattern.</s><s>MF is believed to represent a neoplasm of memory T-cells, reflected in the usual immunoexpression of CD45RO by the malignant cells.</s><s>This contrasts with "native" CD45RO-but CD45RA+ T-cells.</s><s>In the limited previous formal studies, &lt; 9% of MF cases display immunopositivity for this marker (17); a higher fraction was observed in this series -5 of 23 labelled with CD45RA.</s><s>Most patients in the study group followed a protracted, relatively benign, course in accord with classical CD4 MF.</s><s>The findings herein convincingly indicate CD8+ MF to be indistinguishable from the usual CD4+ form of disease, differing only in the single immunphenotypic anomaly; furthermore, they are in agreement with previous authors who contend that CD8 expression, in and of itself, cannot be taken to imply a poor prognosis.</s><s><ref type="bibr" target="#b17">(18,</ref><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b18">19)</ref>, <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24)</ref>.</s><s>The same assertion has been made with regard to the CD4-CD8-variant of otherwise typical MF <ref type="bibr" target="#b24">(25)</ref> and CD56+ disease <ref type="bibr" target="#b50">(51)</ref>.</s><s>Thus, careful clinical assessment for characteristic patches &amp; plaques, or other hallmarks of MF e.g.</s><s>follicular mucinosis, hypopigmentation or poikiloderma, are of critical importance for accurate diagnosis.</s></p><p><s>Similar observations obtain with respect to CD8+ variant lymphomatoid papulosis (LyP), cutaneous anaplastic large cell lymphoma (ALCL) and the solitary form of pagetoid reticulosis (Woringer-Kolopp).</s><s>Interestingly, the presence of haemorrhagic lesions was commented upon in several cases.</s><s>A characteristic wedge-shaped infiltrate of ulcerated skin, containing markedly atypical CD30+ T-cells completed an almost identical picture to classical LyP.</s><s>The clinical observation of haemorrhage was reflected in evidence of this histologically.</s><s>All patients remain alive and well in accord with the benign prognosis of typical LyP, and the reports of previous examples of CD8 LyP <ref type="bibr" target="#b25">(26,</ref><ref type="bibr" target="#b26">27)</ref>.</s><s>Previous literature reports attest to the similarity of the CD8+ form of primary cutaneous ALCL to the classical CD4 disease, including the favourable prognosis <ref type="bibr" target="#b27">(28,</ref><ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b51">52)</ref>.</s><s>Lymphomatoid papulosis type D is a relatively recently distinct form of LyP <ref type="bibr" target="#b30">(31)</ref>, clinically identical to other forms of LyP, but distinctive in the pagetoid reticulosis pattern of epidermotropism and CD8+ phenotype.</s><s>Similarly, LyP type E commonly has a CD8+ phenotype, and displays an angiocentric histology <ref type="bibr" target="#b61">(62)</ref>.</s><s>Thus, the differential diagnosis of these forms of LyP include aggressive epidermotropic CD8+ lymphoma; distinction between these two requires attention to clinical details and the presence or absence of CD30+ atypical cells.</s><s>None of the cases of LyP in this series was of this type; furthermore, no patient in the aggressive CD8+ epidermotropic lymphoma group had a clinical history of waxing and waning papules or nodules to indicate associated LyP of any form, nor did they express CD30.</s></p><p><s>The clinical appearance of the solitary form of pagetoid reticulosis, Woringer-Kolopp, accounted for 2 cases submitted.</s><s>Approximately half of reported cases of pagetoid reticulosis are CD8+ <ref type="bibr" target="#b32">(33,</ref><ref type="bibr" target="#b52">53)</ref>.</s><s>The clinical observations of solitary scaly erythematous acral plaques, the striking histological epidermotropism are typical, and the disease did not progress in either patient.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s></p><p><s>The remaining 18 cases of CD8+ lymphoma did not conform to mycosis fungoides, lymphomatoid papulosis or pagetoid reticulosis.</s><s>Nevertheless, they were distinctive clinically, histologically and immunophenotypically.</s><s>Of the 18 cases, 16 patients initially presented with widespread, often haemorrhagic plaques and extensive tumours.</s></p><p><s>Immunohistochemically, all cases had a CD8+ CD4 -EBV -CD56 -phenotype.</s><s>There is a suggestion of a CD2-CD5-CD45RO-CD45RA+ phenotype, this collective pattern being observed in 7 cases.</s><s>In the physiological transition from naïve (CD45RA+) to memory (CD45RO+) T-cells there is up-regulation of the adhesion molecule, CD2, and therefore a relationship between the expressions of these immuno-markers may be expected.</s><s>Agnarrson was the first to suggest that loss of CD2 expression correlates with a poor prognosis, but this is likely to reflect that such cases in that series were genuine aggressive epidermotropic CD8+ lymphoma, as opposed to the "chronic form" of CD8+ lymphoma viz.</s><s>mycosis fungoides <ref type="bibr" target="#b1">(2)</ref>.</s><s>Although neoplastic cells in MF are typically memory T-cells, and therefore CD45RO+ CD45RA-, the latter can be seen in a small minority of cases (the vast majority of which are CD4+), without an adverse prognosis in the few studied <ref type="bibr" target="#b16">(17)</ref>.</s><s>Indeed, the switch between CD45RA and RO is not irreversible, particularly in the absence of continual antigen stimulation.</s><s><ref type="bibr" target="#b53">(54)</ref>.</s><s>A markedly high proliferative fraction was reflected in at least 50%, often &gt;75%, of malignant cells labelling with MIB-1 (to Ki-67 antigen) in 13 of 17 so investigated, a feature uncommon in tumour MF unless transformation has supervened.</s><s>This has been noted previously <ref type="bibr" target="#b10">(11,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b12">13)</ref>.</s></p><p><s>The basis for this aggressive behaviour remains speculative.</s><s>Urosevic et al postulate that the expression of HLA-G, a non-classical HLA class Ib molecule restricted to immunoprivileged sites, may act to down-regulate the host natural anti-tumour response resulting in rapid evolution of disease.</s><s>They found expression of this molecule in all four cases of CD8+ lymphoma tested <ref type="bibr" target="#b34">(35)</ref>.</s><s>Nevertheless, the variability of prognosis between different forms of CD8+ lymphoma e.g. in comparison to juvenile hypopigmented MF, emphasise the situation is, perhaps, more complex <ref type="bibr" target="#b5">(6,</ref><ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b18">19)</ref>.</s><s>These cases are distinct from known and accepted forms of cutaneous lymphoma.</s><s>One proffered interpretation is that these tumours represent an aggressive form of mycosis fungoides.</s><s>However, the cases of CD8+ MF in this series, and others, convincingly demonstrate that clinically typical CD8+ MF follows a natural course of progression identical to the commonplace CD4+ disease <ref type="bibr" target="#b23">(24)</ref>.</s><s>Furthermore, the relatively short history of widespread ulcerated haemorrhagic nodules and tumours is not the usual clinical presentation of MF, but invites a different differential diagnosis, including cutaneous γδ lymphoma and Ketron-Goodman disease.</s><s>Most circulating T-cells express the αβ chain in the T-cell receptor with &lt; 5% of the γδ subtype.</s><s>The latter are the neoplastic cell in the aggressive γδ lymphoma, which may present a clinical picture very similar to primary cutaneous CD8+ lymphoma, and has a similarly dismal prognosis.</s><s>Cutaneous γδ lymphoma, however, has a CD4-CD8-CD56+ immunophenotype in the vast majority of instances <ref type="bibr" target="#b36">(37)</ref>; moreover, by definition, the malignant cells will be negative for the beta chain of the T-cell receptor.</s><s>Although two of the cases in this series were also negative for beta-F1, this does not prove that the malignant T-cells were of γδ type, as the antigen may simply fail to be expressed.</s><s>In both cases the malignant cells had a CD8+ CD56-phenotype, which is not that typically seen in γδ lymphomas.</s><s>Furthermore, a frozen section of one of these tumours was also negative for T-cell receptor δ.</s><s>Nevertheless, although in the majority of cases the tumour cells of γδ lymphomas are CD8-, a small</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s><s>physiological population of CD4-CD8+ γδ T-cells is known to exist <ref type="bibr" target="#b37">(38,</ref><ref type="bibr" target="#b54">55)</ref>.</s><s>The possibility that some cases of primary cutaneous CD8+ lymphoma are a rare form of γδ cutaneous lymphoma can not always be excluded; nevertheless, most examples of γδ lymphoma are CD56+, not seen in any of our cases, and immunolabelling for beta-F1 excludes those tested in our series.</s></p><p><s>A few case reports do suggest that in rare cases, this aggressive lymphoma can be preceded by a lengthy prodromal period <ref type="bibr" target="#b38">(39,</ref><ref type="bibr" target="#b39">40)</ref>, although in Ito et al the histology of the original lesions dating 10 years previously had not been presented or discussed; moreover, the relationship of the lymphoma to the long history of psoriasis in Weenig et al is uncertain.</s><s>At least one case has been linked to HTLV-1 infection, <ref type="bibr" target="#b40">(41)</ref> although the authors' did not demonstrate viral integration into neoplastic cells.</s><s>Finally, a single case with anomalous expression of CD15 has been reported <ref type="bibr" target="#b41">(42)</ref>.</s><s>Interestingly, the possibility of therapy inducing a CD8+ lymphoma, or worsening prognosis in this lymphoma, has been postulated by several authors <ref type="bibr" target="#b13">(14,</ref><ref type="bibr" target="#b55">56)</ref> &amp; attributed to augmentation of Th1 immunity.</s></p><p><s>Previous reports by some of the authors (1,9) have indicated the difficulties in making the distinction between aggressive epidermotropic CD8+ lymphoma and other forms of CD8+ T-cell lymphoma.</s><s>However, the analysis of this large series indicates that other recognisable forms of CD8+ T-cell lymphoma present diagnostic histological features not seen in any of these cases eg CD30 expression in lymphomatoid papulosis &amp; anaplastic lymphoma.</s><s>Conversely, unlike MF, there are few or no Pautrier microabscesses despite considerable epidermotropism, there is a pagetoid reticulosis pattern of epidermotropism and the neoplastic cytology is more monotonous than is usual in MF.</s><s>Finally, immunhistochemistry suggests distinct phenotypes.</s></p><p><s>Patients with the disseminated form of pagetoid reticulosis (Ketron-Goodman disease) present with multiple ulcerated plaques and tumours at various sites, similar to patients in our series, and often have a poor prognosis <ref type="bibr" target="#b42">(43,</ref><ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b44">45)</ref>.</s><s>It is likely that many patients diagnosed with disseminated pagetoid reticulosis have either aggressive epidermotropic CD8+ or cutaneous γδ lymphoma; a minority may represent rare examples of aggressive MF.</s><s>Previous reports of disseminated pagetoid reticulosis detail variable phenotypes, including a CD4-CD8-phenotype <ref type="bibr" target="#b42">(43,</ref><ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b44">45,</ref><ref type="bibr" target="#b56">57,</ref><ref type="bibr" target="#b57">58)</ref> (and may, therefore, represent γδ lymphomas), and CD8+ CD4- <ref type="bibr" target="#b42">(43,</ref><ref type="bibr" target="#b58">59,</ref><ref type="bibr" target="#b59">60)</ref> (therefore representing aggressive epidermotropic cutaneous CD8+ lymphoma).</s></p><p><s>The two patients that presented with more limited tumorous facial lesions had an appearance that resembled extranodal NK/T-cell lymphoma and blastic plasmacytoid dendritic cell neoplasm.</s><s>Both are readily excluded by the immunophenotype; in particular, the absence of EBV expression is an exceptional event, if seen at all, in NK/T-cell disease.</s><s>A single case of aggressive epidermotropic CD8+ lymphoma mimicking extranodal NK/T-cell lymphoma has been previously reported <ref type="bibr" target="#b45">(46)</ref>.</s><s>In one patient there were more widespread plaques on the trunk, and there was subsequent rapid development of multiple plaques and tumours in the other patient.</s></p><p><s>Recently, a report of two cases and review of the literature by Nofal et al, proposed diagnostic criteria for aggressive epidermotropic CD8+ cutaneous lymphoma <ref type="bibr" target="#b46">(47)</ref>.</s><s>Our data support many of the suggested criteria; for diagnosis, we emphasise the acute presentation of plaques/tumours, often ulcerated/haemorrhagic, mucosal involvement is not rare; histologically, the finding of a pagetoid reticulosis pattern of epidermotropism, and angiocentricity, together with a CD8+ CD45RA+ phenotype, Ki-67 &gt; 75%; either CD56(-) or</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s><s>betaF1+, and expression of one or more of TIA-1 or granzyme B. Whilst not a constant finding, focal or complete loss of one of CD2 or CD5 is also common; previous reports have documented a similar pattern.</s><s>Proposed diagnostic criteria are listed in table <ref type="table" target="#tab_4">4</ref>.</s></p><p><s>Cutaneous lymphomas should be considered, in terms of diagnosis and management, on the collective bases of clinical appearance, pathological findings and immunophenotype rather than any of these parameters in isolation.</s><s>It is the view of the workshop panel that, on current evidence, aggressive epidermotropic CD8+ lymphoma has a recognisable clinical presentation, histopathology and immunphenotype, and should be classified as a specific lymphoma in future revisions of the WHO lymphoma classification.</s><s>Finally, in view of the very poor prognosis, a multicentre clinical trial using aggressive therapy might be considered in the future to try &amp; improve survival for patients with this disease.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1d .</head><label>1d</label><figDesc><div><p><s>Fig. 1d.</s><s>A plaque of CD8+ mycosis fungoides on the lower limb.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 1g .</head><label>1g</label><figDesc><div><p><s>Fig. 1g.</s><s>Survival curves of patients with CD8+ mycosis fungoides &amp; aggressive epidermotropic CD8+ lymphoma</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>Figs. 3a-d.</s><s>A pagetoid reticulosis pattern of epidermotropsim was characteristic of aggressive epidermotropic CD8+ lymphoma, without Pautrier microabscesses in the vast majority of biopsies (H&amp;E, x200)</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 7</head><label>7</label><figDesc><div><p><s>Fig. 7 Tumour cells of aggressive epidermotropic CD8+ lymphoma were mostly medium sized, and whilst markedly atypical, never large or blastic (H&amp;E, a x200, b x400).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head></head><label></label><figDesc><div><p><s>Figs 8a-d.</s><s>Immunocytochemistry in cutaneous aggressive epidermotropic CD8+ lymphoma: a) diffuse expression of CD8 b) CD45RA and c) loss of CD5 expression.: d) a high proliferative fraction with Ki-67 was characteristic (x100).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head></head><label></label><figDesc><div><p><s>negative for T-cell receptor δ on frozen section.</s><s>All cases demonstrated T-cell clonality by analysis of T-cell receptor.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 2 Cases of Mycosis fungoides, Lymphomatoid papulosis and Pagetoid Reticulosis with a CD8+ phenotype Figs. 1a, b &amp; c. Three examples of patients with patches of CD8+ mycosis fungoides, indistinguishable from classical CD4+ disease.</head><label>2</label><figDesc></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 .Antibodies used for immunophenotyping.</head><label>1</label><figDesc></figDesc><table><row><cell>Antibody specificity</cell><cell>Species &amp; type</cell><cell>Clone</cell><cell>Source</cell></row><row><cell>Conditions</cell><cell></cell><cell></cell><cell></cell></row><row><cell>CD2</cell><cell>Mouse IgG1</cell><cell></cell><cell>AB75</cell><cell>Novocastra</cell></row><row><cell>EDTA; 1/40</cell><cell></cell><cell></cell><cell></cell></row><row><cell>CD3</cell><cell cols="3">Rabbit, monoclonal 2GV6</cell><cell>Ventana</cell></row><row><cell>EDTA; pre-diluted</cell><cell></cell><cell></cell><cell></cell></row><row><cell>CD4</cell><cell cols="2">Rabbit, polyclonal</cell><cell>SP35</cell><cell>Ventana</cell></row><row><cell>EDTA; pre-diluted</cell><cell></cell><cell></cell><cell></cell></row><row><cell>CD5</cell><cell>Mouse, IgG1</cell><cell></cell><cell>4C7</cell><cell>Novocastra</cell></row><row><cell>EDTA; 1/50 dilution</cell><cell></cell><cell></cell><cell></cell></row><row><cell>CD8</cell><cell cols="3">Rabbit, monoclonal SP57</cell><cell>Ventana</cell></row><row><cell>EDTA; pre-diluted</cell><cell></cell><cell></cell><cell></cell></row><row><cell>CD7</cell><cell>Mouse, IgG2b</cell><cell></cell><cell>LP15</cell><cell>Novocastra</cell></row><row><cell>EDTA; 1/20</cell><cell></cell><cell></cell><cell></cell></row><row><cell>CD45RO</cell><cell>Mouse, IgG2A</cell><cell></cell><cell>UCHL-1</cell><cell>BioGenex</cell></row><row><cell>1/200</cell><cell></cell><cell></cell><cell></cell></row><row><cell>CD45RA</cell><cell>Mouse, IgG1</cell><cell></cell><cell>4KB5</cell><cell>DakoCytomation</cell></row><row><cell>1/50; citrate</cell><cell></cell><cell></cell><cell></cell></row><row><cell>CD56</cell><cell>Mouse, IgG1</cell><cell></cell><cell>1B6</cell><cell>Novocastra</cell></row><row><cell>EDTA; 1/50</cell><cell></cell><cell></cell><cell></cell></row><row><cell>TIA-1</cell><cell>Mouse, IgG1</cell><cell></cell><cell>2G9A10F5</cell><cell>Beckman Coulter</cell></row><row><cell>1/200; citrate</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Granzyme B</cell><cell>Mouse, IgG2A</cell><cell></cell><cell>11F1</cell><cell>Novocastra</cell></row><row><cell>1/30; citrate</cell><cell></cell><cell></cell><cell></cell></row><row><cell>BetaF1</cell><cell>Mouse, IgG1</cell><cell>8A3</cell><cell cols="2">ThermoScientific</cell></row><row><cell>1/15; trypsin</cell><cell></cell><cell></cell><cell></cell></row><row><cell>MIB-1</cell><cell>Mouse, IgG1</cell><cell></cell><cell>MIB-1</cell><cell>DakoCytomation</cell></row><row><cell>1/5; citrate</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 Cases of Mycosis fungoides, Lymphomatoid papulosis and Pagetoid Reticulosis with a CD8+ phenotype</head><label>2</label><figDesc></figDesc><table><row><cell>Age/sex</cell><cell>Clinical features</cell><cell>Therapy</cell><cell>Outcome</cell><cell></cell></row><row><cell cols="2">Time period* Diagnosis</cell><cell></cell><cell></cell><cell></cell></row><row><cell>54 male</cell><cell>patches buttocks 35 years</cell><cell>Chemo</cell><cell>A+D</cell><cell>48</cell></row><row><cell>months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>19 male</cell><cell>papules on limbs</cell><cell>DXT</cell><cell>A+W</cell><cell>68</cell></row><row><cell>months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>42 male</cell><cell>erythematosus lesions buttock</cell><cell>DXT</cell><cell>A+W</cell><cell>72</cell></row><row><cell>months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>7 4 m a l e</cell><cell>p u r p u r a l e g s</cell><cell>N K</cell><cell>A + D</cell><cell>2 2</cell></row><row><cell>months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>26 female</cell><cell>10 patches hips/arms</cell><cell>Topical</cell><cell>A+D</cell><cell>22</cell></row><row><cell>months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>31 male</cell><cell>scaly papules</cell><cell>PUVA</cell><cell>A+D</cell><cell>36</cell></row><row><cell>months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>56 female</cell><cell>erythematous papules</cell><cell>Chemo</cell><cell>A+W</cell><cell>12</cell></row><row><cell>months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3b Immunophenotype of Primary Cutaneous Aggressive Epidermotropic CD8+ Lymphoma cases*</head><label>3b</label><figDesc><div><p><s>All cases were CD8+, CD4-.</s><s>None labelled with CD56 or antibodies to LMP, and all were negative with insitu hybridisation for EBER.</s></p></div></figDesc><table><row><cell></cell><cell cols="2">23 female</cell><cell cols="2">petechial patches</cell><cell></cell><cell>DXT</cell><cell></cell><cell>A+D</cell><cell>120</cell></row><row><cell cols="2">months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Case</cell><cell cols="2">39 female CD 2 CD5</cell><cell cols="3">poikiloderma, sacral tumour CD7 CD45RO CD45RA</cell><cell cols="2">DXT, PUVA MIB-1 Beta-F1</cell><cell>A+D</cell><cell>47</cell></row><row><cell cols="2">months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>1</cell><cell>52 male -</cell><cell>+/-</cell><cell cols="2">poikiloderma, plaques -+/-</cell><cell>+</cell><cell cols="2">Chemo/DXT + +</cell><cell>A+D</cell><cell>180</cell></row><row><cell cols="2">months MF 2 +/-</cell><cell>+</cell><cell>-</cell><cell>ND</cell><cell>ND</cell><cell cols="2">+++ +</cell><cell></cell></row><row><cell>3</cell><cell>40 male -</cell><cell>+</cell><cell cols="2">erythrodermic, HIV+ -+/-</cell><cell>+</cell><cell cols="4">Chemotherapy Died of disease 7 + -</cell></row><row><cell cols="4">months Erythrodermic MF 4 ---</cell><cell>ND</cell><cell>ND</cell><cell>+++</cell><cell>ND</cell><cell></cell></row><row><cell>5</cell><cell cols="2">58 female -+</cell><cell cols="3">erythematous hyperkeratotic lesions + -+</cell><cell cols="3">Chemotherapy Unknown ++ +</cell><cell>NA</cell></row><row><cell>6</cell><cell>-</cell><cell>M F -</cell><cell>+</cell><cell>-</cell><cell>+</cell><cell>+++</cell><cell>+</cell><cell></cell></row><row><cell>7</cell><cell cols="2">55 female ND ND</cell><cell cols="3">psoriasioform patches/plaques + ND +</cell><cell cols="4">PUVA, Chemo Died of disease 132 +++ +</cell></row><row><cell cols="2">months MF 8 -</cell><cell>-</cell><cell>-</cell><cell>-</cell><cell>+</cell><cell>+++</cell><cell>-**</cell><cell></cell></row><row><cell>9</cell><cell>60 male +</cell><cell>-</cell><cell cols="3">eczematous lesions -plaques/nodules + -+</cell><cell cols="3">PUVA, retinoids A+D ++ +**</cell><cell>120</cell></row><row><cell cols="2">months MF 10 -</cell><cell>-</cell><cell>-</cell><cell>-</cell><cell>+</cell><cell>+++</cell><cell>+</cell><cell></cell></row><row><cell>11</cell><cell>30 male -</cell><cell>-</cell><cell cols="3">poikilodermatous scaly lesions + -+</cell><cell cols="3">PUVA, Chemo A+D ++ +</cell><cell>132</cell></row><row><cell cols="2">months MF 12 +</cell><cell>+</cell><cell>ND</cell><cell>-</cell><cell>+/-</cell><cell>ND</cell><cell>ND</cell><cell></cell></row><row><cell>13</cell><cell>89 male -</cell><cell>-</cell><cell cols="2">psoriasioform patches --</cell><cell>+/-</cell><cell>NR +++</cell><cell>ND</cell><cell>A+D</cell><cell>16</cell></row><row><cell cols="2">months MF 14 +</cell><cell>+</cell><cell>-</cell><cell>+</cell><cell>+</cell><cell>+++</cell><cell>ND**</cell><cell></cell></row><row><cell>15</cell><cell cols="2">50 female --</cell><cell cols="2">atrophic patches buttocks + -</cell><cell>+</cell><cell>UVB +++</cell><cell>ND</cell><cell>A+D</cell><cell>72</cell></row><row><cell cols="2">months MF 16 -</cell><cell>-</cell><cell>+</cell><cell>-</cell><cell>+</cell><cell>+</cell><cell>ND</cell><cell></cell></row><row><cell>17</cell><cell cols="2">30 female --</cell><cell cols="3">erythematous scaly patches -ND -</cell><cell>PUVA ND</cell><cell>ND</cell><cell>A+W</cell><cell>30</cell></row><row><cell cols="2">months MF 18 ND</cell><cell>ND</cell><cell>-</cell><cell>-</cell><cell>+</cell><cell>+++</cell><cell>ND</cell><cell></cell></row><row><cell></cell><cell cols="2">43 female</cell><cell cols="2">atropic patch buttock</cell><cell></cell><cell>DXT</cell><cell></cell><cell>A+W</cell><cell>42</cell></row><row><cell cols="2">months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>51 male</cell><cell></cell><cell cols="2">patches buttock/hip</cell><cell></cell><cell cols="2">local steroids</cell><cell>A+D</cell><cell>60</cell></row><row><cell cols="2">months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>49 male</cell><cell></cell><cell cols="2">generalised patches</cell><cell></cell><cell>PUVA</cell><cell></cell><cell>A+W</cell><cell>120</cell></row><row><cell cols="2">months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>51 male</cell><cell></cell><cell cols="2">patches on back</cell><cell></cell><cell>PUVA</cell><cell></cell><cell>A+D</cell><cell>360</cell></row><row><cell cols="2">months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>4 4 m a l e</cell><cell></cell><cell cols="2">a t r o p i c p a t c h e s a r m s / l e g s</cell><cell></cell><cell>P U V A</cell><cell></cell><cell>A + W</cell><cell>4 3</cell></row><row><cell cols="2">months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell cols="2">39 female</cell><cell cols="2">generalised patches</cell><cell></cell><cell>PUVA</cell><cell></cell><cell>A+D</cell><cell>40</cell></row><row><cell cols="2">months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>69 male</cell><cell></cell><cell cols="2">patches axillae/groins</cell><cell></cell><cell>PUVA</cell><cell></cell><cell>A+W</cell><cell>11</cell></row><row><cell cols="2">months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>82 male</cell><cell></cell><cell cols="3">scalp erosions, plaques, nodules</cell><cell>DXT</cell><cell></cell><cell>A+D</cell><cell>36</cell></row><row><cell cols="2">months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>65 male</cell><cell></cell><cell cols="2">patches and plaques</cell><cell></cell><cell>Steroids</cell><cell></cell><cell>A+D</cell><cell>49</cell></row><row><cell cols="2">months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>46 male</cell><cell></cell><cell cols="2">scaly patches</cell><cell></cell><cell>PUVA</cell><cell></cell><cell>A+D</cell><cell>72</cell></row><row><cell cols="2">months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell cols="2">52 female</cell><cell cols="2">Widespread patches</cell><cell></cell><cell>PUVA</cell><cell></cell><cell>A+D</cell><cell>36</cell></row><row><cell cols="2">months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>62 male</cell><cell></cell><cell cols="2">poikiloderma</cell><cell></cell><cell>PUVA</cell><cell></cell><cell>A+D</cell><cell>24</cell></row><row><cell cols="2">months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell cols="2">56 female</cell><cell cols="2">patch on thigh</cell><cell></cell><cell>topical</cell><cell></cell><cell>A+W</cell><cell>36</cell></row><row><cell cols="2">months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell cols="2">46 female</cell><cell cols="3">psoriasioform patches,plaque arms</cell><cell>DXT</cell><cell></cell><cell>A+D</cell><cell>36</cell></row><row><cell cols="2">months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell cols="2">55 female</cell><cell cols="2">generalised patches</cell><cell></cell><cell cols="2">PUVA, DXT</cell><cell>A+D</cell><cell>72</cell></row><row><cell cols="2">months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>50 male</cell><cell></cell><cell cols="2">patches/plaques</cell><cell></cell><cell cols="3">Many therapies A+D</cell><cell>72</cell></row><row><cell cols="2">months MF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>51 male</cell><cell></cell><cell cols="3">ulceronecrotic lesions arm/leg</cell><cell cols="2">local steroids</cell><cell>A+W</cell><cell>34</cell></row><row><cell cols="2">months LyP</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>38 male</cell><cell></cell><cell cols="3">ulceronecrotic lesions arm/hip</cell><cell>-</cell><cell></cell><cell>A+W</cell><cell>10</cell></row><row><cell cols="2">months LyP</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>*</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 4 Proposed diagnostic criteria for the diagnosis of Primary Cutaneous Aggressive Epidermotropic CD8+ Lymphoma Clinical features Histology Immunohistochemistry</head><label>4</label><figDesc></figDesc><table><row><cell>Plaques and tumours</cell><cell>Pagetoid reticulosis pattern</cell><cell>CD8+ CD56(-)</cell></row><row><cell>No history of patches,</cell><cell>+/-apoptotic keratinocytes</cell><cell>At least 1 of CD2(-), CD5(-) or</cell></row><row><cell>evidence of follicular</cell><cell></cell><cell>CD45RA(+)</cell></row><row><cell>mucinosis or poikiloderma</cell><cell>Monomorphic atypia</cell><cell>Ki-67&gt; 50%</cell></row><row><cell></cell><cell></cell><cell>B e t a F 1 ( + ) o r T C R δ(-)</cell></row><row><cell>Staging confirms only</cell><cell></cell><cell>EBER(-)</cell></row><row><cell>cutaneous disease</cell><cell></cell><cell></cell></row><row><cell>No immunosuppression</cell><cell></cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>Dr David Loras, Clinical Epidemiology Unit, Hospital Universitario, Madrid, for statistical analysis.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s><s>association with CCR7-positive conversion.</s><s>Dermatol Online J. 2012; Oct 15;18 <ref type="bibr" target="#b9">(10)</ref>:5.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">WHO -EORTC classification for cutaneous lymphomas</title>
		<author>
			<persName><forename type="first">R</forename><surname>Willemze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Jaffe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Burg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="3768" to="3785" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Cutaneous T-cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Agnarsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Vonderheid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Kadin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Acad Dermatol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="569" to="577" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Fatal CD8+ epidermotropic cytotoxic primary cutaneous T-cell lymphoma with multi-organ involvement</title>
		<author>
			<persName><forename type="first">A</forename><surname>Marzano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ghislanzoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Gianelli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dermatology</title>
		<imprint>
			<biblScope unit="volume">211</biblScope>
			<biblScope unit="page" from="281" to="285" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Rapidly progressive CD8-positive cutaneous T-cell lymphoma with tongue involvement</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Quaterman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Lesher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Davis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Dermatopathol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="287" to="291" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Clinical and pathological spectrum of CD8-positive cutaneous T-cell lymphomas</title>
		<author>
			<persName><forename type="first">D</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Duvic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cutan Pathol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="465" to="472" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Junctional CD8+ cutaneous lymphomas with non-aggressive clinical behaviour</title>
		<author>
			<persName><forename type="first">R</forename><surname>Dummer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kamarashev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kempf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Dermatol</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="199" to="203" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Pleomorphic CD8+ small/medium size cutaneous T-cell lymphoma</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Khamaysi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ben_Arieh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Epelbaum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Dermatopathol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="434" to="437" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Primary cutaneous T-cell lymphoma of unspecified type with cytotoxic phenotype: clinicopathological analysis of 27 patients</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hagiwara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Takata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shimoyama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Sci</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="33" to="41" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas</title>
		<author>
			<persName><forename type="first">E</forename><surname>Berti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Tomasini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vermeer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="page" from="483" to="492" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<title level="m" type="main">Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: transformation from indolent to aggressive phase in</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kasuya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hirakawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tokura</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma; report of two cases with no evidence of systemic disease</title>
		<author>
			<persName><forename type="first">A</forename><surname>Szepesi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Csomor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Rajnai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Dermatol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="690" to="691" />
			<date type="published" when="2012-09">2012. Sep-Oct</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title level="m" type="main">Primary cutaneous CD8-positive T-cell lymphoma: a case report of a rare and aggressive disease with oral presentation. Dent Update</title>
		<author>
			<persName><forename type="first">A</forename><surname>Geddes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Savin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>White</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2011-09">2011. Sep</date>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page">476</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Six-year-old girl with primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kikuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kashii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Gunji</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatrics Int</title>
		<imprint>
			<biblScope unit="page" from="393" to="396" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Gormley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Hess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Anand</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Acad Dermatol</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="300" to="307" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Introcaso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gardner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Dermatol</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1027" to="1029" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Rare provisional entity: primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma in a young woman</title>
		<author>
			<persName><forename type="first">J</forename><surname>Csomar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bognar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bednedek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Pathol</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="770" to="772" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Fierro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Novelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Savoia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cutan Pathol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="356" to="362" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Juvenile onset mycosis fungoides: an immunohistochemical and genotypic analysis of six cases</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Whittam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Calonje</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Orchard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Dermatol</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="page" from="1199" to="1204" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Hypopigmented mycosis fungoides. Frequent expression of a CD8+ T-cell phenotype</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Shabrawi-Caelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cerroni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Medeiros</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Surg Pathol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="450" to="457" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">CD8+ mycosis fungoides with esophageal involvement: a case report</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ishida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Mochizuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Saito</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncol Lett</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="73" to="75" />
			<date type="published" when="2013-01">2013. Jan</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Poikilodermatous mycosis fungoides with a CD8+ CD56+ immunophenotype: a case report and literature review</title>
		<author>
			<persName><forename type="first">T</forename><surname>Shiomi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Monobe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kuwabara</surname></persName>
		</author>
		<idno type="DOI">10.1111/cup.12067</idno>
	</analytic>
	<monogr>
		<title level="j">J Cutan Pathol</title>
		<imprint>
			<date type="published" when="1927">2012. Nov. 27</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">CD4/CD8 dual-positive mycosis fungoides: a previously unrecognised variant</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Knapp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mathew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Messina</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Dermatopathol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="e37" to="39" />
			<date type="published" when="2012-05">2012. May</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Hyperpigmented mycosis fungoides: an unusual variant of cutaneous T-cell lymphoma with a frequent CD8+ phenotype</title>
		<author>
			<persName><forename type="first">L</forename><surname>Pavlovsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mimouni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Amitay-Laish</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Acad Dermatol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="69" to="75" />
			<date type="published" when="2012-07">2012. Jul</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Nikolaou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Papadavid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Katsambas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Dermatol</title>
		<imprint>
			<biblScope unit="volume">161</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="826" to="830" />
			<date type="published" when="2009-10">2009. Oct</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">CD4/CD8 double negative epidermotropic cutaneous T-cell lymphoma; an immunohistochemical variant of mycosis fungoides</title>
		<author>
			<persName><forename type="first">E</forename><surname>Hodak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>David</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Maron</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Acad Dermatol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="276" to="284" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Three cases of lymphomatoid papulosis with a CD56+ immunophenotype</title>
		<author>
			<persName><forename type="first">S</forename><surname>Flann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Orchard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Wain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Acad Dermatol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="903" to="906" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Plaza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Feldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Magro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cutan Pathol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="236" to="247" />
			<date type="published" when="2013-02">2013. Feb</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">CD8-positive primary cutaneous anaplastic large cell lymphoma with a fair prognosis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Fukunaga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Masaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ichihashi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Derm Venereol</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="312" to="314" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">CD-8positive primary cutaneous anaplastic large Tcell lymphoma (PCALCL): case report and review of this unusual variant of PCALCL</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Plaza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ortega</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lynott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Dermatopathol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="489" to="491" />
			<date type="published" when="2010-07">2010. Jul</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">CD8-positive primary cutaneous anaplastic large cell lymphoma presenting as multiple scrotal nodules and plaques</title>
		<author>
			<persName><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Qian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wei</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Dermatol</title>
		<imprint>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases</title>
		<author>
			<persName><forename type="first">A</forename><surname>Saggini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gulia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Argenyi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Surg Pathol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1168" to="1175" />
			<date type="published" when="2010-08">2010. Aug</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Progressive epidermotropic CD8+/CD4-primary cutaneous CD30+ lymphoproliferative disorder in a patient with sarcoidosis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gelfand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Wasik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Vittorio</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Acad Dermatol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="304" to="308" />
			<date type="published" when="2004-08">2004. Aug</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Pagetoid reticulosis (Woringer-Kolopp disease): an immunophenotypic, molecular and clinicopathological study</title>
		<author>
			<persName><forename type="first">B</forename><surname>Haghighi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Smoller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Leboit</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mod Pathol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="502" to="510" />
			<date type="published" when="2000-05">2000. May</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Stage-dependent expression of CD7, CD45RO, CD45RA and CD25 on CD4-positive peripheral blood T-lymphocytes in cutaneous T-cell lymphoma</title>
		<author>
			<persName><forename type="first">T</forename><surname>Jakob</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Neuber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Altenhoff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Derm Venereol (Stockh)</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="34" to="36" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2</title>
		<author>
			<persName><forename type="first">M</forename><surname>Urosevic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kamarashev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Burg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="1796" to="1798" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Mycosis fungoides with a CD56+ immunophenotype</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Wain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Orchard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mayou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Acad Dermatol</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="158" to="163" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Cutaneous gamma-delta T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas</title>
		<author>
			<persName><forename type="first">J</forename><surname>Guitart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Weisenburger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Subtil</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Surg Pathol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1656" to="1665" />
			<date type="published" when="2012-11">2012. Nov</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Gamma-delta T-cell lymphoma of the skin</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Toro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beaty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sorbara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Dermatol</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="1024" to="1032" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Fatal cytotoxic cutaneous lymphoma presenting as ulcerative psoriasis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Weenig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">I</forename><surname>Comfere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Gibson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Dermatol</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="801" to="808" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Epidermotropic CD8+ cytotoxic T-cell lymphoma exhibiting a transition from the indolent to the aggressive phase, accompanied by emergence of CD7+ cells and formation of neutrophilic pustules</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Goto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hatano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Dermatol</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="128" to="131" />
			<date type="published" when="2012-03">2012. Mar</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma in a human T-cell leukaemia virus type-1 carrier</title>
		<author>
			<persName><forename type="first">H</forename><surname>Ohmatsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sugaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fujita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Derm Venereol</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="324" to="325" />
			<date type="published" when="2010-05">2010. May</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15(+) CD30(-) phenotype</title>
		<author>
			<persName><forename type="first">N</forename><surname>Yoshizawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yagi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Horibe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Dermatol</title>
		<imprint>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Localized and disseminated pagetoid reticulosis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Mielke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wolff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Winzer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Dermatol</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="402" to="406" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Disseminated pagetoid reticulosis (Ketron-Goodman disease): six year follow up</title>
		<author>
			<persName><forename type="first">T</forename><surname>Nakada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sueki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Iijima</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Acad Dermatol</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="S182" to="186" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Disseminated pagetoid reticulosis presenting as cytotoxic CD4/CD8 double negative cutaneous T-cell lymphoma</title>
		<author>
			<persName><forename type="first">G</forename><surname>Paganelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bianchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cantonetti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Derm Venereol</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="314" to="316" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Cutaneous peripheral T-cell lymphoma of cytotoxic phenotype mimicking extranodal NK/T-cell lymphoma</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Murphy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Dermatopathol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="e17" to="20" />
			<date type="published" when="2011-04">2011. Apr</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation</title>
		<author>
			<persName><forename type="first">A</forename><surname>Nofal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Abdel-Mawla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Assaf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Acad Dermatol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="748" to="759" />
			<date type="published" when="2012-10">2012. Oct</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Primary cutaneous γ/δ T-cell lymphoma presenting as disseminated pagetoid reticulosis</title>
		<author>
			<persName><forename type="first">E</forename><surname>Berti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cerri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cavicchini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Invest Dermatol</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="718" to="723" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Bekkenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vermeer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Jansen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="2213" to="2219" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma clinically simulating pyoderma gangrenosum</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Tu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Dermatol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="e261" to="262" />
			<date type="published" when="2009-10">2009. Oct</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">mycosis fungoides with a CD56+ immunophenotype</title>
		<author>
			<persName><forename type="first">M</forename><surname>Wain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Orchard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mayou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Acad Dermatol</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="158" to="163" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">CD8+ cutaneous anaplastic large cell lymphoma; report of two cases with immunophenotyping, T-cell receptor gene rearrangement and electron microscopic studies</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kikuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sakuraoka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kurihara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Dermatol</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="404" to="408" />
			<date type="published" when="1992">1992. 1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Woringer-Kolopp disease. A lymphomatoid hypersensitivity reaction</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Crowson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Magro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Dermatopathol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="542" to="548" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Interconversion of CD45R subsets of CD4 T cells in vivo</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Bell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Sparshott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">348</biblScope>
			<biblScope unit="page">163</biblScope>
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Tissue localisation and CD8 accessory molecule expression of T γδ cells in humans</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Bucy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Clh</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Cooper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">142</biblScope>
			<biblScope unit="page" from="3045" to="3049" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Rapid onset of CD8+ aggressive T-cell lymphoma during bexarotene therapy in a patient with Sezary syndrome</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kreuter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Altmeyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Acad Dermatol</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1093" to="1095" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">CD4-CD8-&apos;double negative&apos; cutaneous T-cell lymphomas share common histologic features and an aggressive clinical course</title>
		<author>
			<persName><forename type="first">D</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Vega</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Sarris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Surg Pathol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="225" to="231" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Primary cutaneous gamma/delta T-cell lymphoma presenting as disseminated pagetoid reticulosis</title>
		<author>
			<persName><forename type="first">E</forename><surname>Berti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cerri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cavicchini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Invest Dermatol</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="718" to="723" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">H</forename><surname>Luther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bacharach-Buhles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Schultz-Ehrenburg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pagetoid Retikulose vom Typ Ketron-Goodman (In German). Hautarzt</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="530" to="535" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Lymphome purement epidermotrope type (Ketron Goodman) (In French)</title>
		<author>
			<persName><forename type="first">H</forename><surname>Cotton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Janin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gross</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Pathol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="117" to="121" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kamarashev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Burg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Mingari</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1593" to="1597" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas</title>
		<author>
			<persName><forename type="first">W</forename><surname>Kempf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">V</forename><surname>Kazakov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Schärer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Surg Pathol</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="13" />
			<date type="published" when="2013-01">2013 Jan</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
